. . . . . . . "[Since iron regulatory protein 1 (IRP1) is known to inhibit the translation of HIF2?, we investigated whether Tempol, a stable nitroxide that activates IRP1 towards IRE-binding, might have a therapeutic effect on a panel of human CCRCC cells expressing both HIF1? and HIF2?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:14+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .